3-(3-Methoxyphenyl)oxetan-3-amine hydrochloride, 95.0%, 250mg

1,4-Bis(2-methylstyryl)benzene, 98.0%, 5g

Methyl 3-(pyridin-4-yl)acrylate, 95.0%, 5g

5-(4-(2-(Methyl(pyridin-2-yl)amino)ethoxy)benzyl)thiazolidine-2,4-dione, 98.0%, 100g

Gránulos de oro, mínimo 99,95 %, 1-6 mm, 5 g, envase de vidrio

1-(3,5-Bis(trifluoromethyl)phenyl)ethanamine hydrochloride, 95.0%, 250mg

2-Iodo-3-nitropyridine, 95+%, 100mg

N-isopropyl-2-(piperazin-1-yl)propanamide, 95.0%, 250mg

Benzeneacetamide, N-[(1S)-2-[[(7S)-6,7-dihydro-5-methyl-6-oxo-5H-dibenz[b,d]azepin-7-yl]amino]-1-methyl-2-oxoethyl]-3,5-difluoro-, 97%, 5mg

Bis(2-ethoxyethyl) adipate, 98.0%, 25g

Methyl 2,3-o-isopropylidene-beta-D-ribofuranoside, 95.0%, 25g

3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one, 97.0%, 5g

1-(4-Bromophenyl)pyrrolidin-2-one, 95.0%, 5g